We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

94 hedge funds and large institutions have $78.9M invested in iShares US Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

24,167% more call options, than puts

Call options by funds: $728K | Put options by funds: $3K

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

3% more funds holding

Funds holding: 91 → 94 (+3)

4.72% less ownership

Funds ownership: 72.49% → 67.77% (-4.7%)

6% less capital invested

Capital invested by funds: $83.7M → $78.9M (-$4.8M)

21% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 28

Holders
94
Holders Change
+3
Holders Change %
+3.3%
% of All Funds
1.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
28
Closed
10
Calls
$728K
Puts
$3K
Net Calls
+$725K
Net Calls Change
-$304K

Top Buyers

Rank Fund Capital Flow
1
CFGS
Concourse Financial Group Securities
Alabama
+$3.63M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.08M
3
Bank of America
Bank of America
North Carolina
+$565K
4
Wells Fargo
Wells Fargo
California
+$499K
5
FTUS
Flow Traders U.S.
New York
+$387K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$5.15M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.13M
3
Stifel Financial
Stifel Financial
Missouri
-$1.15M
4
SRSA
S.R. Schill & Associates
Washington
-$990K
5
TRCT
Tower Research Capital (TRC)
New York
-$953K
Name Holding Trade Value Shares
Change 		Change in
Stake
FFW
76
Fusion Family Wealth
New York
$28K – – –
HWA
77
HHM Wealth Advisors
Tennessee
$25K – – –
Fifth Third Bancorp
78
Fifth Third Bancorp
Ohio
$23K – – –
NFG
79
Next Financial Group
Texas
$20K +$19.9K +369 New
DSC
80
Duncker Streett & Co
Missouri
$16K – – –
HGWM
81
Harvest Group Wealth Management
Massachusetts
$13K – – –
PFS
82
Prospera Financial Services
Texas
$13K +$12.9K +240 New
AA
83
AlphaMark Advisors
Kentucky
$8K – – –
S
84
SignatureFD
Georgia
$8K – – –
TPWA
85
TRUE Private Wealth Advisors
Oregon
$6K – – –
BC
86
Bartlett & Co
Ohio
$5K – – –
BCWM
87
Bartlett & Co Wealth Management
Ohio
$4.91K – – –
CSPIA
88
Cary Street Partners Investment Advisory
Virginia
$3K +$2.75K +51 New
Simplex Trading
89
Simplex Trading
Illinois
$3K +$3.88K +72 New
MCM
90
Manchester Capital Management
Vermont
$2K – – –
IF
91
Ironwood Financial
Arizona
$2K +$1.94K +36 New
RG
92
Retirement Group
California
$1K – – –
NSIM
93
North Star Investment Management
Illinois
$1K +$1.13K +21 New
Koshinski Asset Management
94
Koshinski Asset Management
Illinois
$592 +$162 +3 +0%
Stifel Financial
95
Stifel Financial
Missouri
– -$1.15M -22,320 Closed
SRSA
96
S.R. Schill & Associates
Washington
– -$990K -19,311 Closed
CFA
97
Carroll Financial Associates
North Carolina
– -$264K -5,148 Closed
CG
98
Cutler Group
California
– -$259K -4,803 Closed
CB
99
Commerce Bank
Missouri
– -$216K -4,215 Closed
EWM
100
Edge Wealth Management
New York
– -$171K -3,327 Closed
1 2 3
4
5

IHE Hedge Fund Activity: Q3 2020 in Review

94 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2020, worth a combined $78.9M — down 5.7% from $83.7M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IHE positions and 10 closed out — a net gain of 4 holders — while 22 added to existing stakes and 28 trimmed.

The largest buyer was Concourse Financial Group Securities, adding an estimated $3.63M. The largest seller was Royal Bank of Canada, cutting an estimated $5.15M.

  • 94 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2020, up from 91 in Q2 2020.
  • Funds reported $78.9M of iShares US Pharmaceuticals ETF stock for Q3 2020, down 5.7% quarter-over-quarter.
  • 14 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2020 and 10 closed out, a net change of +4 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2020 was Concourse Financial Group Securities, an estimated $3.63M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2020 was Royal Bank of Canada, an estimated $5.15M sold.

Based on aggregated 13F filings for Q3 2020.